Dymista in Chinese Adolescents | MicrobiomeTrials← Back to trialsNCT07597473
Dymista in Chinese Adolescents
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2026-05-08Est. Completion: 2026-10
Enrollment target: 100 participants Locations- Capital Center for Children's Health, Capital Medical University, Beijing, China
- Hunan Provincial People's Hospital, Changsha, China
- Sichuan Provincial People's Hospital, Chengdu, China
- Dalian Municipal Central Hospital, Dalian, China
- Affiliated Hangzhou First people's hospital, School of Medicine, Westlake University, Hangzhou, China
- Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China
- The Second Affiliated Hospital of Nanchang University, Nanchang, China
- Eye & Ent Hospital of Fudan University, Shanghai, China
- The Second Affiliated Hospital of Shanxi Medical University, Taiyuan, China
- Tianjin Union Medical Center/Nankai University Affiliated Hospital, Tianjin, China
- The Central Hospital of Wuhan, Wuhan, China
- Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
- The Second Affiliated Hospital of Xi'an JiaotongUniversity(XibeiHospital), Xi'an, China
- Central Hospital of Zibo, Zibo, China
Other microbiome trials you might be interested in
Food Allergy in ChildrenOral Immunotherapy for Food Allergy
The goal of this clinical trial is to learn whether oral immunotherapy (OIT) is safe and effective for treating food all…
Herlev, DenmarkEst. completion Mar 1, 2031
Allergic RhinitisSeasonal Allergic RhinitisRagweed AllergyBirch Pollen Allergy
The ragweed Ambrosia artemisiifolia is spreading in northern Europe due to climate change. The pollen are considered hig…
Hanover, GermanyCompleted Dec 6, 2024